PMID- 37355492 OWN - NLM STAT- MEDLINE DCOM- 20230905 LR - 20230907 IS - 1573-6830 (Electronic) IS - 0272-4340 (Print) IS - 0272-4340 (Linking) VI - 43 IP - 7 DP - 2023 Oct TI - APP-BACE1 Interaction and Intracellular Localization Regulate Abeta Production in iPSC-Derived Cortical Neurons. PG - 3653-3668 LID - 10.1007/s10571-023-01374-0 [doi] AB - Alzheimer's disease (AD) is characterized pathologically by amyloid beta (Abeta)-containing plaques. Generation of Abeta from amyloid precursor protein (APP) by two enzymes, beta- and gamma-secretase, has therefore been in the AD research spotlight for decades. Despite this, how the physical interaction of APP with the secretases influences APP processing is not fully understood. Herein, we compared two genetically identical human iPSC-derived neuronal cell types: low Abeta-secreting neuroprogenitor cells (NPCs) and high Abeta-secreting mature neurons, as models of low versus high Abeta production. We investigated levels of substrate, enzymes and products of APP amyloidogenic processing and correlated them with the proximity of APP to beta- and gamma-secretase in endo-lysosomal organelles. In mature neurons, increased colocalization of full-length APP with the beta-secretase BACE1 correlated with increased beta-cleavage product sAPPbeta. Increased flAPP/BACE1 colocalization was mainly found in early endosomes. In the same way, increased colocalization of APP-derived C-terminal fragment (CTF) with presenilin-1 (PSEN1), the catalytic subunit of gamma-secretase, was seen in neurons as compared to NPCs. Furthermore, most of the interaction of APP with BACE1 in low Abeta-secreting NPCs seemed to derive from CTF, the remaining APP part after BACE1 cleavage, indicating a possible novel product-enzyme inhibition. In conclusion, our results suggest that interaction of APP and APP cleavage products with their secretases can regulate Abeta production both positively and negatively. beta- and gamma-Secretases are difficult targets for AD treatment due to their ubiquitous nature and wide range of substrates. Therefore, targeting APP-secretase interactions could be a novel treatment strategy for AD. Colocalization of APP species with BACE1 in a novel model of low- versus high-Abeta secretion-Two genetically identical human iPSC-derived neuronal cell types: low Abeta-secreting neuroprogenitor cells (NPCs) and high Abeta secreting mature neurons, were compared. Increased full-length APP (flAPP)/BACE1 colocalization in early endosomes was seen in neurons, while APP-CTF/BACE1 colocalization was much higher than flAPP/BACE1 colocalization in NPCs, although the cellular location was not determined. CI - (c) 2023. The Author(s). FAU - Roselli, Sandra AU - Roselli S AUID- ORCID: 0000-0003-2998-3760 AD - Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Bla Straket 15, Sahlgrenska Hospital, 405 30, Gothenburg, Sweden. sandra.roselli@gu.se. FAU - Satir, Tugce Munise AU - Satir TM AUID- ORCID: 0000-0001-9021-1650 AD - Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Bla Straket 15, Sahlgrenska Hospital, 405 30, Gothenburg, Sweden. FAU - Camacho, Rafael AU - Camacho R AUID- ORCID: 0000-0003-2325-6407 AD - Centre for Cellular Imaging, Core Facilities, The Sahlgrenska Academy, University of Gothenburg, Medicinaregatan 7A, 405 30, Gothenburg, Sweden. FAU - Fruhwurth, Stefanie AU - Fruhwurth S AUID- ORCID: 0000-0003-4035-7330 AD - Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Bla Straket 15, Sahlgrenska Hospital, 405 30, Gothenburg, Sweden. FAU - Bergstrom, Petra AU - Bergstrom P AUID- ORCID: 0000-0003-1803-165X AD - Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Bla Straket 15, Sahlgrenska Hospital, 405 30, Gothenburg, Sweden. FAU - Zetterberg, Henrik AU - Zetterberg H AUID- ORCID: 0000-0003-3930-4354 AD - Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Bla Straket 15, Sahlgrenska Hospital, 405 30, Gothenburg, Sweden. AD - Clinical Neurochemistry Laboratory, Sahlgrenska University Hospital, Building V3, Molndal Hospital, 431 80, Molndal, Sweden. AD - Department of Neurodegenerative Disease, Institute of Neurology, University College London Queen Square, Queen Square, London, WC1N 3BG, UK. AD - UK Dementia Research Institute at UCL, Cruciform Building, Gower Street, London, WC1E 6BT, UK. AD - Hong Kong Center for Neurodegenerative Diseases, Units 1501-1502, 1512-1518, 15/F, Building 17W, Hong Kong Science Park, Shatin, N.T., Hong Kong, China. AD - Wisconsin Alzheimer's Disease Research Center, University of Wisconsin School of Medicine and Public Health, University of Wisconsin-Madison, 600 Highland Avenue, Madison, WI, 53792, USA. FAU - Agholme, Lotta AU - Agholme L AUID- ORCID: 0000-0003-3816-7474 AD - Institute of Neuroscience and Physiology, Department of Psychiatry and Neurochemistry, The Sahlgrenska Academy at the University of Gothenburg, Bla Straket 15, Sahlgrenska Hospital, 405 30, Gothenburg, Sweden. LA - eng GR - 681712/ERC_/European Research Council/International PT - Journal Article DEP - 20230624 PL - United States TA - Cell Mol Neurobiol JT - Cellular and molecular neurobiology JID - 8200709 RN - 0 (Amyloid beta-Protein Precursor) RN - 0 (Amyloid beta-Peptides) RN - EC 3.4.- (Amyloid Precursor Protein Secretases) RN - EC 3.4.23.- (Aspartic Acid Endopeptidases) RN - EC 3.4.23.46 (BACE1 protein, human) SB - IM MH - Humans MH - Amyloid beta-Protein Precursor MH - Amyloid beta-Peptides MH - Amyloid Precursor Protein Secretases MH - Aspartic Acid Endopeptidases MH - *Induced Pluripotent Stem Cells MH - *Alzheimer Disease MH - Neurons PMC - PMC10477112 OTO - NOTNLM OT - Amyloid beta OT - Amyloid precursor protein OT - Beta secretase OT - Early endosomes OT - Gamma secretase OT - Neurons OT - Proximity ligation assay COIS- Henrik Zetterberg has served at scientific advisory boards and/or as a consultant for Abbvie, Alector, Annexon, Artery Therapeutics, AZTherapies, CogRx, Denali, Eisai, Nervgen, Novo Nordisk, Pinteon Therapeutics, Red Abbey Labs, Passage Bio, Roche, Samumed, Siemens Healthineers, Triplet Therapeutics, and Wave, has given lectures in symposia sponsored by Cellectricon, Fujirebio, Alzecure, Biogen, and Roche, and is a co-founder of Brain Biomarker Solutions in Gothenburg AB (BBS), which is a part of the GU Ventures Incubator Program. The other authors report no conflicts of interest. EDAT- 2023/06/25 01:08 MHDA- 2023/09/05 06:42 PMCR- 2023/06/24 CRDT- 2023/06/24 23:03 PHST- 2022/12/08 00:00 [received] PHST- 2023/06/09 00:00 [accepted] PHST- 2023/09/05 06:42 [medline] PHST- 2023/06/25 01:08 [pubmed] PHST- 2023/06/24 23:03 [entrez] PHST- 2023/06/24 00:00 [pmc-release] AID - 10.1007/s10571-023-01374-0 [pii] AID - 1374 [pii] AID - 10.1007/s10571-023-01374-0 [doi] PST - ppublish SO - Cell Mol Neurobiol. 2023 Oct;43(7):3653-3668. doi: 10.1007/s10571-023-01374-0. Epub 2023 Jun 24.